The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

References

• Apelseth TO, Hervig T, Bruserud O. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood Rev 2011; 25: 113–122
   PubMed Web of Science ®Google Scholar
• Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med 2003; 163: 59–64
   PubMed Web of Science ®Google Scholar
• de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: Interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008; 65: 795–803
   PubMed Web of Science ®Google Scholar
• van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study. BMJ 2001; 323: 655–658
   PubMed Web of Science ®Google Scholar
• Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: A new look. Br J Clin Pharmacol 2008; 66(1)76–81
   PubMed Web of Science ®Google Scholar
• Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L, Crowell MD, Keshavarzian A, Jones MP. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis. Aliment Pharmacol Ther 2006; 23: 937–944
   PubMed Web of Science ®Google Scholar
• Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: A review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010; 71: 1565–1575
   PubMed Web of Science ®Google Scholar
• van Haelst IM, Egberts TC, Doodeman HJ, Traast HS, Burger BJ, Kalkman CJ, van Klei WA. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology 2010; 112: 631–636
   PubMed Web of Science ®Google Scholar
• Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003; 163: 2354–2358
   PubMed Web of Science ®Google Scholar
• Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003; 115: 851–862
   PubMed Web of Science ®Google Scholar
• Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Aberg A. Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. Psychopharmacology (Berl) 1980; 67: 1–7
   PubMed Web of Science ®Google Scholar
• McCloskey DJ, Postolache TT, Vittone BJ, Nghiem KL, Monsale JL, Wesley RA, Rick ME. Selective serotonin reuptake inhibitors: Measurement of effect on platelet function. Transl Res 2008; 151: 168–172
   PubMed Web of Science ®Google Scholar
• Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000; 68: 435–442
   PubMed Web of Science ®Google Scholar
• Hervig T, Volundardottir T, Bakken AM, Farstad M. Thrombin-induced serotonin release as an in vitro indicator of the functional integrity of stored platelets. Clin Chem 1990; 36: 28–31
   PubMed Web of Science ®Google Scholar
• Hervig TA, Farstad M. Human blood platelet serotonin studied in vitro: Endogenous serotonin may stimulate thrombin-induced serotonin release in stored platelets. Platelets 1996; 7: 53–57
   PubMed Web of Science ®Google Scholar
• Hervig TA, Farstad M, Vollset SE. Endogenous serotonin in human blood platelets: Factors that may influence reference values. Platelets 1996; 7: 47–52
   PubMed Web of Science ®Google Scholar
• Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, Hervig T. Thrombelastography. Transfus Apher Sci 2009; 40: 119–123
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T. Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or plasmalyte. Transfusion 2010; 50: 2199–2209
   PubMed Web of Science ®Google Scholar
• Kotzailias N, Andonovski T, Dukic A, Serebruany VL, Jilma B. Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: A randomized, placebo-controlled, double-blind trial. J Clin Pharmacol 2006; 46: 468–475
   PubMed Web of Science ®Google Scholar
• Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Buller HR, Schene AH, Kamphuisen PW. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 2008; 6: 2168–2174
   PubMed Web of Science ®Google Scholar
• Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: Confusion or confounding?. Am J Med 2006; 119: 719–727
   PubMed Web of Science ®Google Scholar
• Serebruany VL, O’Connor CM, Gurbel PA. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 2001; 87: 1398–1400
   PubMed Web of Science ®Google Scholar
• Breddin HK. Can platelet aggregometry be standardized?. Platelets 2005; 16: 151–158
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Gurbel PA, O’Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001; 43: 453–462
   PubMed Web of Science ®Google Scholar
• Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, Baron A, Hanson SR, Nemeroff CB. Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings. Arch Gen Psychiatry 2000; 57: 875–882
   PubMed Web of Science ®Google Scholar
• Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: Evidence for a treatment effect. J Thromb Haemost 2009; 7: 573–581
   PubMed Web of Science ®Google Scholar
• Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986; 78: 130–137
   Google Scholar
• Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877–11882
   PubMed Web of Science ®Google Scholar
• Hervig T, Flesland O, Svenningsen V, Bosnes V. Guidelines for transfusion in Norway. Transfus Apher Sci 2004; 31: 181–184
   PubMed Web of Science ®Google Scholar